Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells.
Imidazolidine-2-one
breast hypoxia
carbonic anhydrase inhibitors
glioblastoma
imidazolin-2-one
pancreatic hypoxia
ureido linker
Journal
Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
entrez:
29
6
2022
pubmed:
30
6
2022
medline:
2
7
2022
Statut:
ppublish
Résumé
Among the chemotypes studied for selective inhibition of tumour-associated carbonic anhydrases (CAs),
Identifiants
pubmed: 35768159
doi: 10.1080/14756366.2022.2091557
pmc: PMC9246135
doi:
Substances chimiques
Antigens, Neoplasm
0
Carbonic Anhydrase Inhibitors
0
Sulfonamides
0
Carbonic Anhydrase IX
EC 4.2.1.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1857-1869Références
Int J Mol Sci. 2020 Dec 09;21(24):
pubmed: 33317057
J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
Chem Commun (Camb). 2020 Nov 4;56(85):13033-13036
pubmed: 33000794
J Enzyme Inhib Med Chem. 2022 Dec;37(1):280-286
pubmed: 34894950
JCI Insight. 2017 Dec 21;2(24):
pubmed: 29263302
Bioinformatics. 2017 Nov 15;33(22):3658-3660
pubmed: 28961788
Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1279-82
pubmed: 3759546
Mol Pharm. 2016 Mar 7;13(3):1137-46
pubmed: 26866675
Am J Clin Oncol. 2020 Jul;43(7):484-490
pubmed: 32251122
Eur J Med Chem. 2017 May 26;132:184-191
pubmed: 28363153
Chem Rev. 2012 Aug 8;112(8):4421-68
pubmed: 22607219
Anticancer Res. 2011 Oct;31(10):3369-75
pubmed: 21965748
Cancer Res. 2001 Oct 15;61(20):7603-7
pubmed: 11606400
J Med Chem. 2011 Mar 24;54(6):1896-902
pubmed: 21361354
Cancer Treat Rev. 2013 Apr;39(2):171-9
pubmed: 23063837
Biochem J. 2016 Jul 15;473(14):2023-32
pubmed: 27407171
Int J Biol Macromol. 2022 Mar 15;201:37-46
pubmed: 34999037
Eur J Med Chem. 2022 Mar 15;232:114190
pubmed: 35182815
Adv Exp Med Biol. 2019;1136:123-139
pubmed: 31201721
Anticancer Agents Med Chem. 2022;22(14):2637-2646
pubmed: 35135455
J Exp Clin Cancer Res. 2021 Jan 11;40(1):28
pubmed: 33423689
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Oncol Rep. 2019 Apr;41(4):2585-2594
pubmed: 30720123
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
Expert Opin Investig Drugs. 2021 Dec;30(12):1197-1208
pubmed: 34865569
Gastroenterology. 2019 Sep;157(3):823-837
pubmed: 31078621
J Enzyme Inhib Med Chem. 2019 Dec;34(1):117-123
pubmed: 30362384
Cancers (Basel). 2021 Mar 09;13(5):
pubmed: 33803236
J Biol Chem. 1971 Apr 25;246(8):2561-73
pubmed: 4994926
J Enzyme Inhib Med Chem. 2019 Dec;34(1):75-86
pubmed: 30362386
Subcell Biochem. 2014;75:291-323
pubmed: 24146385
Int J Cancer. 2010 Oct 1;127(7):1535-46
pubmed: 20091868
Med Res Rev. 2018 Sep;38(6):1799-1836
pubmed: 29635752
Oncoimmunology. 2018 Mar 26;7(7):e1445452
pubmed: 29900055
J Exp Clin Cancer Res. 2022 Apr 2;41(1):122
pubmed: 35365193
Cancers (Basel). 2019 Jul 17;11(7):
pubmed: 31319613
J Exp Pharmacol. 2020 Dec 15;12:603-617
pubmed: 33364855
J Med Chem. 2018 Jul 26;61(14):6328-6338
pubmed: 29962205
J Med Chem. 2021 Feb 11;64(3):1713-1724
pubmed: 33523653
Sci Adv. 2021 Aug 27;7(35):
pubmed: 34452919
Cancer Res. 2008 Jan 15;68(2):605-14
pubmed: 18199558
J Enzyme Inhib Med Chem. 2021 Dec;36(1):954-963
pubmed: 33947294
Bioorg Med Chem Lett. 2013 Dec 15;23(24):6759-63
pubmed: 24189056